Results and prognostic factors in retrobulbar radiotherapy combined with systemic corticosteroids for endocrine orbitopathy (Graves' disease)

Frontiers of Radiation Therapy and Oncology

Volumn 30, Issue , 1997, Pages 206-217

  Staar, S ^a   Muller R P ^a   Hammer, M ^a   Nolte, M ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; EYE MOVEMENT; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; ORAL DRUG ADMINISTRATION; PROGNOSIS; PROSPECTIVE STUDY; RADIATION RESPONSE; RETROSPECTIVE STUDY;

ADMINISTRATION, ORAL; ADULT; AGED; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; EYE MOVEMENTS; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; GRAVES DISEASE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0030629925     PISSN: 00719676     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (37)

1. Graves RJ: Clinical Lectures. London Med Surg J 1835;7:515-519.
2. Sergott RC, Glaser JS: Graves' ophthalmopathy: A clinical and immunological review. Surv Ophthalmol 1981;26:1-21.
3. Ingbar SH: The role of antibodies and other humoral factors in the pathogenesis of Graves' disease; in Drexhage HA, Wiersinga WM (eds): The Thyroid and Autoimmunity. Amsterdam, Elsevier, 1986, pp 3-14.
4. Topliss D, Volpe R: The immunology of autoimmune thyroid disease. Thyroid Today 1982;5:1-5.
5. Sisler HA, Jakobiec FA, Trokel SL: Ocular abnormalities and orbital changes of Graves' disease; in Duane TD, Jaeger EA (eds): Clinical Ophthalmology, vol 2 rev ed. Philadelphia, Harper & Row, 1985, pp 1-30.
6. Newell IW: Ophthalmology Principles and Concepts, ed 6. St. Louis, Mosby, 1986.
7. Utinger RD: Hyperthyroidism; in Green WL (ed): The Thyroid. New York, Elsevier, 1987, pp 157-218.
8. Trokel SL, Hilal SK: Recognition and differential diagnosis of enlarged extraocular muscle in computed tomography. Am J Ophthalmol 1979;87:503-512.
9. Kazim M, Trokel SL, Moore S: Treatment of acute Graves' orbitopathy. Ophthalmology 1991;98: 1443-1448.
10. Hallin ES, Feldon SE: Graves' ophthalmopathy. II. Correlation of clinical signs with measures derived from computed tomography. Br J Ophthalmol 1988;72:678-682.
11. Wiersinga WM, Smit T, van der Gaag R: Clinical presentation of Graves' ophthalmopathy. Ophthalmic Res 1989;21:73-82.
12. Spector RH, Carlisle JA: Minimal thyroid ophthalmopathy. Neurology 1987;37:1803-1808.
13. Brown J, Coburn JW, Wigod RA: Adrenal steroid therapy of severe infiltrative ophthalmopathy of Graves' disease. Am J Med 1963;63:786-795.
14. Werner SC: Prednisone in emergency treatment of malignant exophthalmus. Lancet 1966;1:1004-1007.
15. Apers RC, Oosterhius JA, Bierlaagh JJM: Indications and results of prednisone treatment in thyroid ophthalmopathy. Ophthalmologica 1976;173:163-167.
16. McConahey WM: Medical therapy; in Gormen CA, Waller RR, Dyer JA (eds): The Eye and Orbit in Thyroid Disease. New York, Raven Press, 1984, pp 317-324.
17. Bartalena L, Marcocci C, Bogazzi F, et al: The use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 1989;321: 1349-1352.
18. Dollinger J: Die Druckentlastung der Augenhöhle durch Entfernung der äußeren Orbitawand bei hochgradigem Exophthalmus (Morbus Basedow) und konsekutiver Hornhauterkrankung. Dtsch Med Wochenschr 1911;37:1888-1890.
19. Thomas HM, Woods AC: Progressive exophthalmus following thyroidectomy. Bull Hopkins Hosp 1936;59:99-113.
20. Donaldson SS, Bagshaw MA, Kriss JP: Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab 1973;37:276-285.
21. Donaldson SS, Kriss JP, McDougall IR, et al: Orbital irradiation in the treatment of Graves' ophthalmopathy: Results in 141 consecutive patients (abstract). Int J Radiat Oncol Biol Phys 1982; 8:112-113.
22. Peterson Ja, Kriss JP, McDougall IR, et al: Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys 1990;19:259-264.
23. Marcocci C, Bartalena L, Marconcini C, et al: Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves' ophthalmopathy: A comparative study. Clin Endocrinol 1987;27:33-42.
24. Fries PD: Thyroid dysfunction: Managing the ocular complications of Graves' disease. Geriatrics 1992;2:58-70.
25. Werner SC: Classification of the eye changes of Graves' disease. J Clin Endocrinol Metab 1969;29: 982.
26. Werner SC: Modification of the classification of the eye changes of Graves' disease. Am J Ophthalmol 1977;83:725-727.
27. Yamamoto K, Saito K, Takai T, et al: Treatment of Graves' ophthalmopathy by steroid therapy, orbital radiation therapy, plasmapheresis, and thyroxine replacement. Endocrinol Jpn 1982;29: 495-501.
28. Bartalena L, Marcocci C, Chiovato L, et al: Orbital irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: Comparison with systemic corticosteroids alone. J Endocrinol Metab 1983;56:1139-1144.
29. Bartalena L, Marcocci C, Bogazzi F, et al: Glucocorticoid therapy of Graves' ophthalmopathy. Exp Clin Endocrinol 1991;97:320-327.
30. Hosten N, Sander B, Cordes M, et al: Graves' ophthalmopathy: MR imaging of the orbits. Radiology 1989;172:759-762.
31. Forrester JV, Sutherland GR, McDougall IR: Dythyroid ophthalmopathy: Orbital evaluation with B-scan ultrasonography. J Clin Endocrinol Metab 1977;45:221-224.
32. Erickson BA, Harris GJ, Lewandowski MF, et al: Echographic monitoring of response of extraocular muscles to irradiation in Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys 1995;31:651-660.
33. Burch HB, Wartofsky L: Graves' ophthalmopathy: Current concepts regarding pathogenesis and management. Endocr Rev 1993;14:747-793.
34. Tallstedt L, Lundell G, Torring O, et al: Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. N Engl J Med 1992;326:1733-1738.
35. Tallstedt L, Lundell G, Blomgren H, et al: Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? Eur J Endocrinol 1994;130: 494-497.
36. Hurley JR: Orbitopathy after treatment of Graves' disease. J Nucl Med 1994;35:918-920.
37. DeGroot LJ, Gorman CA, Pinchera A, et al: Therapeutic controversies: Radiation and Graves' ophthalmopathy. J Clin Endocrinol Metab 1995;80:339-349.